Pancrelipase Articles
Stock Commentary - Europe - week to Sept 3, 2007
10 September 2007
Solvay's Creon gets FDA "approvable" letter
3 September 2007
Analysts expectant on future prospects for Canada's Axcan Pharma
13 February 2001
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
